Insmed
INSM
#542
Rank
$43.50 B
Marketcap
$204.00
Share price
-0.51%
Change (1 day)
170.56%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -$1.11 Billion USD

According to Insmed's latest financial reports the company's current earnings are $0.44 Billion USD. In 2024 the company made an earning of -$0.83 Billion USD a decrease over its 2023 earnings that were of -$0.68 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$1.11 Billion32.67%
2024 -$0.83 Billion23.71%
2023 -$0.68 Billion45.77%
2022 -$0.47 Billion15.83%
2021 -$0.4 Billion50.19%
2020 -$0.27 Billion16.4%
2019 -$0.23 Billion-23.9%
2018 -$0.3 Billion59.35%
2017 -$0.19 Billion8.52%
2016 -$0.18 Billion47.25%
2015 -$0.12 Billion34.53%
2014 -$87.17 Million58.83%
2013 -$54.89 Million35.14%
2012 -$40.62 Million-31.92%
2011 -$59.66 Million854.92%
2010 -$6.25 Million-105.22%
2009 $0.11 B-905.06%
2008 -$14.86 Million-27.31%
2007 -$20.44 Million-62.41%
2006 -$54.38 Million98.19%
2005 -$27.44 Million0.03%
2004 -$27.43 Million159.07%
2003 -$10.59 Million-69.31%
2002 -$34.5 Million
2000 -$31.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-$0.26 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.41 B-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
$9.88 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
$4.41 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-$23.25 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$4.46 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA